Citation
Select
Kosior D, Szulc M, Zawadzka M, PierScinska M, Stawicki S, Rabczenko D, Torbicki A, Opolski G.
[Role of amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation] [Polish] Original Title: Rola amiodaronu w utrzymaniu rytmu zatokowego po skutecznej kardiowersji elektrycznej u chor
Pol Arch Med Wewn. 2002 Dec;108(6):1151-60
Citation
Select
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group.
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation (RACE Study)
N Engl J Med. 2002 Dec 5;347(23):1834-40
Citation
Select
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators.
A comparison of rate control and rhythm control in patients with atrial fibrillation (The AFFIRM Study)
N Engl J Med. 2002 Dec 5;347(23):1825-33
Citation
Select
Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S; ERAFT Investigators.
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)
Am J Cardiol. 2002 Dec 15;90(12):1300-6